Autochthonous hepatitis e virus infections: A new transfusion-associated risk?

Transfusion Medicine and Hemotherapy

Volumn 41, Issue 1, 2014, Pages 29-39

  Dreier, Jens ^a   Juhl, David ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Hepatitis E virus; HEV blood donor screening; HEV RNA; Incidence; Seroprevalence; Transfusion transmission; Transfusion transmitted HEV infection

Indexed keywords

HEPATITIS E ANTIBODY; HEPATITIS E ANTIGEN; HEPATITIS E VACCINE; VIRUS RNA;

ACTIVE IMMUNIZATION; BLOOD DONOR; BLOODBORNE BACTERIUM; DEVELOPED COUNTRY; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; LABORATORY DIAGNOSIS; MORTALITY; OCCUPATIONAL EXPOSURE; PERSONAL HYGIENE; PREVENTION AND CONTROL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; SEROPREVALENCE; TRANSFUSION MEDICINE;

EID: 84901673215     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000357098     Document Type: Review

References (132)

1. Payne CJ, Ellis TM, Plant SL, et al.: Sequence data suggests big liver and spleen disease virus (blsv) is genetically related to hepatitis E virus. Vet Microbiol 1999;68:119-125.
2. Batts W, Yun S, Hedrick R, Winton J: A novel member of the family hepeviridae from cutthroat trout (oncorhynchus clarkii). Virus Res 2011;158: 116-123.
3. Lu L, Li C, Hagedorn CH: Phylogenetic analysis of global hepatitis E virus sequences: Genetic diversity, subtypes and zoonosis. Rev Med Virol 2006; 16:5-36.
4. Meng XJ: Hepatitis E virus: Animal reservoirs and zoonotic risk. Vet Microbiol 2010;140:256-265.
5. Purdy MA, Khudyakov YE: The molecular epidemiology of hepatitis E virus infection. Virus Res 2011;161:31-39.
6. Aggarwal R, Jameel S: Hepatitis E. Hepatology 2011;54:2218-2226.
7. Casas M, Martin M: Hepatitis E virus and pigs: A zoonotic risk in Europe Vet J 2010;186:135-136.
8. Bachlein C, Grummer B: [Hepatitis E-A new zoonotic disease in Germany?]. Berl Munch Tierarztl Wochenschr 2010;123:198-204.
9. Smith DB, Purdy MA, Simmonds P: Genetic variability and the classification of hepatitis E virus. J Virol 2013;87:4161-4169.
10. Drexler JF, Seelen A, Corman VM, et al.: Bats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family hepeviridae. J Virol 2012;86:9134-9147.
11. Johne R, Heckel G, Plenge-Bonig A, et al.: Novel hepatitis E virus genotype in norway rats, Germany. Emerg Infect Dis 2010;16:1452-1455.
12. Purcell RH, Emerson SU: Hidden danger: The raw facts about hepatitis E virus. J Infect Dis 2010;202: 819-821.
13. Schielke A, Sachs K, Lierz M, et al.: Detection of hepatitis E virus in wild boars of rural and urban regions in Germany and whole genome characterization of an endemic strain. Virol J 2009;6:58.
14. Kaci S, Nockler K, Johne R: Detection of hepatitis E virus in archived German wild boar serum samples. Vet Microbiol 2008;128:380-385.
15. Baechlein C, Schielke A, Johne R, et al.: Prevalence of hepatitis E virus-specific antibodies in sera of German domestic pigs estimated by using different assays. Vet Microbiol 2010;144:187-191.
16. Kamar N, Bendall R, Legrand-Abravanel F, et al.: Hepatitis E. Lancet 2012;379:2477-2488.
17. Pelosi E, Clarke I: Hepatitis E: A complex and global disease. Emerg Health Threats J 2008;1:e8.
18. Lewis HC, Wichmann O, Duizer E: Transmission routes and risk factors for autochthonous hepatitis E virus infection in europe: A systematic review. Epidemiol Infect 2010;138:145-166.
19. Boxall E, Herborn A, Kochethu G, et al.: Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus Med 2006;16:79-83.
20. Colson P, Coze C, Gallian P, et al.: Transfusion-Associated hepatitis E, france. Emerg Infect Dis 2007; 13:648-649.
21. Matsubayashi K, Nagaoka Y, Sakata H, et al.: Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004;44:934-940.
22. Matsubayashi K, Kang JH, Sakata H, et al.: A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008; 48:1368-1375.
23. Tamura A, Shimizu YK, Tanaka T, et al.: Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007;37:113-120.
24. Mitsui T, Tsukamoto Y, Yamazaki C, et al.: Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: Evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol 2004;74:563-572.
25. Khuroo MS, Kamili S, Yattoo GN: Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol 2004;19:778-784.
26. Guo QS, Yan Q, Xiong JH, et al.: Prevalence of hepatitis E virus in chinese blood donors. J Clin Microbiol 2010;48:317-318.
27. Sakata H, Matsubayashi K, Takeda H, et al.: A nationwide survey for hepatitis E virus prevalence in japanese blood donors with elevated alanine aminotransferase. Transfusion 2008;48:2568-2576.
28. Vollmer T, Diekmann J, Johne R, et al.: Novel approach for detection of hepatitis E virus infection in German blood donors. J Clin Microbiol 2012;50: 2708-2713.
29. Baylis SA, Gartner T, Nick S, et al.: Occurrence of hepatitis E virus RNA in plasma donations from sweden, Germany and the United States. Vox Sang 2012;103:89-90.
30. Arbeitskreis Blut UBBK: Hepatitis E virus. Transfus Med Hemother 2009;36:40-47.
31. Waar K, Herremans MM, Vennema H, et al.: Hepatitis E is a cause of unexplained hepatitis in the netherlands. J Clin Virol 2005;33:145-149.
32. Balayan MS, Andjaparidze AG, Savinskaya SS, et al.: Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983;20:23-31.
33. Sainokami S, Abe K, Kumagai I, et al.: Epidemiological and clinical study of sporadic acute hepatitis E caused by indigenous strains of hepatitis E virus in Japan compared with acute hepatitis A. J Gastroenterol 2004;39:640-648.
34. World Health Organization DoCDSaR: Hepatitis E. 2001
35. Said B, Ijaz S, Kafatos G, et al.: Hepatitis E outbreak on cruise ship. Emerg Infect Dis 2009;15: 1738-1744.
36. Dalton HR, Stableforth W, Thurairajah P, et al.: Autochthonous hepatitis E in southwest England: Natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008;20:784-790.
37. Pfefferle S, Frickmann H, Gabriel M, et al.: Fatal course of an autochthonous hepatitis E virus infection in a patient with leukemia in Germany. Infection 2012;40:451-454.
38. Dalton HR, Hazeldine S, Banks M, et al.: Locally acquired hepatitis E in chronic liver disease. Lancet 2007;369:1260.
39. Jilani N, Das BC, Husain SA, et al.: Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol 2007;22:676-682.
40. Patra S, Kumar A, Trivedi SS, et al.: Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007;147: 28-33.
41. Gerolami R, Moal V, Picard C, Colson P: Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol 2009; 50:622-624.
42. Gerolami R, Moal V, Colson P: Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008;358:859-860.
43. Kamar N, Selves J, Mansuy JM, et al.: Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008;358:811-817.
44. Halac U, Beland K, Lapierre P, et al.: Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant. J Pediatr 2012;160:871-874 e871.
45. de Niet A, Zaaijer HL, ten Berge I, et al.: Chronic hepatitis E after solid organ transplantation. Neth J Med 2012;70:261-266.
46. Pischke S, Stiefel P, Franz B, et al.: Chronic hepatitis E in heart transplant recipients. Am J Transplant 2012;12:3128-3133.
47. Olsen B, Axelsson-Olsson D, Thelin A, Weiland O: Unexpected high prevalence of IgG-Antibodies to hepatitis E virus in Swedish pig farmers and controls. Scand J Infect Dis 2006;38:55-58.
48. Ijaz S, Vyse AJ, Morgan D, et al.: Indigenous hepatitis E virus infection in England: More common than it seems. J Clin Virol 2009;44:272-276.
49. Van Hoecke F, Van Maerken T, De Boulle M, et al.: Hepatitis E seroprevalence in East and West Flanders, Belgium. Acta Gastroenterol Belg 2012; 75:322-324.
50. Kaba M, Brouqui P, Richet H, et al.: Hepatitis E virus infection in sheltered homeless persons, France. Emerg Infect Dis 2010;16:1761-1763.
51. Rapicetta M, Kondili LA, Pretolani S, et al.: Seroprevalence and anti-HEV persistence in the general population of the republic of San Marino. J Med Virol 1999;58:49-53.
52. Vulcano A, Angelucci M, Candelori E, et al.: HEV prevalence in the general population and among workers at zoonotic risk in Latium region. Ann Ig 2007;19:181-186.
53. Fogeda M, Avellon A, Echevarria JM: Prevalence of specific antibody to hepatitis E virus in the general population of the community of Madrid, Spain. J Med Virol 2012;84:71-74.
54. Krumbholz A, Mohn U, Lange J, et al.: Prevalence of hepatitis E virus-specific antibodies in humans with occupational exposure to pigs. Med Microbiol Immunol 2012;201:239-244.
55. Faber MS, Wenzel JJ, Jilg W, et al.: Hepatitis E virus seroprevalence among adults, Germany. Emerg Infect Dis 2012;18:1654-1657.
56. Preiss JC, Plentz A, Engelmann E, et al.: Autochthonous hepatitis E virus infection in Germany with sequence similarities to other European isolates. Infection 2006;34:173-175.
57. Wichmann O, Schimanski S, Koch J, et al.: Phylogenetic and case-control study on hepatitis E virus infection in Germany. J Infect Dis 2008;198:1732-1741.
58. Lewis HC, Boisson S, Ijaz S, et al.: Hepatitis E in England and Wales. Emerg Infect Dis 2008;14:165-167.
59. Cleland A, Smith L, Crossan C, et al.: Hepatitis E virus in Scottish blood donors. Vox Sang 2013;105: 283-289.
60. Borgen K, Herremans T, Duizer E, et al.: Nontravel related hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004-2006. BMC Infect Dis 2008;8:61.
61. Yazaki Y, Mizuo H, Takahashi M, et al.: Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J Gen Virol 2003;84:2351-2357.
62. Rutjes SA, Lodder WJ, Lodder-Verschoor F, et al.: Sources of hepatitis E virus genotype 3 in the Netherlands. Emerg Infect Dis 2009;15:381-387.
63. Colson P, Borentain P, Queyriaux B, et al.: Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010;202:825-834.
64. Emerson SU, Arankalle VA, Purcell RH: Thermal stability of hepatitis E virus. J Infect Dis 2005;192: 930-933.
65. Mansuy JM, Bendall R, Legrand-Abravanel F, et al.: Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011;17:2309-2312.
66. Mansuy JM, Legrand-Abravanel F, Calot JP, et al.: High prevalence of anti-hepatitis E virus antibodies in blood donors from south west France. J Med Virol 2008;80:289-293.
67. Juhl D, Baylis SA, Blumel J, et al.: Seroprevalence and incidence of hepatitis E virus infection in German blood donors. Transfusion 2013;doi: 10.1111/trf.12121.
68. Xia NS, Zhang J, Zheng YJ, et al.: Transfusion of plasma from a blood donor induced hepatitis E in rhesus monkey. Vox Sang 2004;86:45-47.
69. Haim-Boukobza S, Ferey MP, Vetillard AL, et al.: Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J Hepatol 2012;57:1374-1378.
70. Baylis SA, Koc O, Nick S, Blumel J: Widespread distribution of hepatitis E virus in plasma fractionation pools. Vox Sang 2012;102:182-183.
71. Modrow S, Wenzel JJ, Schimanski S, et al.: Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates. Vox Sang 2011; 100:351-358.
72. Yunoki M, Yamamoto S, Tanaka H, et al.: Extent of hepatitis E virus elimination is affected by stabilizers present in plasma products and pore size of nanofilters. Vox Sang 2008;95:94-100.
73. Aggarwal R: Diagnosis of hepatitis E. Nat Rev Gastroenterol Hepatol 2012;10:24-33.
74. Okamoto H: Hepatitis E virus cell culture models. Virus Res 2011;161:65-77.
75. Rogee S, Talbot N, Caperna T, et al.: New models of hepatitis E virus replication in human and porcine hepatocyte cell lines. J Gen Virol 2013;94:549-558.
76. Shata MT, Barrett A, Shire NJ, et al.: Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay. J Immunol Methods 2007;328:152-161.
77. Engle RE, Yu C, Emerson SU, et al.: Hepatitis E virus (HEV) capsid antigens derived from viruses of human and swine origin are equally efficient for detecting anti-HEV by enzyme immunoassay. J Clin Microbiol 2002;40:4576-4580.
78. Mansuy JM, Peron JM, Bureau C, et al.: Immunologically silent autochthonous acute hepatitis E virus infection in France. J Clin Microbiol 2004;42: 912-913.
79. Nicand E, Grandadam M, Teyssou R, et al.: Viraemia and faecal shedding of HEV in symptom-free carriers. Lancet 2001;357:68-69.
80. Zhang JZ, Im SW, Lau SH, et al.: Occurrence of hepatitis E virus IgM, low avidity IgG serum antibodies, and viremia in sporadic cases of non-A,-B, and-C acute hepatitis. J Med Virol 2002;66:40-48.
81. Bendall R, Ellis V, Ijaz S, et al.: Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol 2008;80:95-101.
82. Ferguson M, Walker D, Mast E, Fields H: Report of a collaborative study to assess the suitability of a reference reagent for antibodies to hepatitis E virus. Biologicals 2002;30:43-48.
83. Yu C, Engle RE, Bryan JP, et al.: Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay. Clin Diagn Lab Immunol 2003;10:579-586.
84. Bendall R, Ellis V, Ijaz S, et al.: A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010;82: 799-805.
85. Drobeniuc J, Meng J, Reuter G, et al.: Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010;51:e24-27.
86. Myint KS, Endy TP, Gibbons RV, et al.: Evaluation of diagnostic assays for hepatitis E virus in outbreak settings. J Clin Microbiol 2006;44:1581-1583.
87. Vollmer T, Diekmann J, Eberhardt M, Knabbe C, Dreier J: Anti-hepatitis E virus antibody seroconversion in ten blood donors with hepatitis E virus infection: Systematic evaluation of test characteristic of seven anti-HEV assays. submitted for publication 2013
88. Takahashi M, Kusakai S, Mizuo H, et al.: Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J Clin Microbiol 2005;43:49-56.
89. Zhang S, Tian D, Zhang Z, et al.: Clinical significance of anti-HEV IgA in diagnosis of acute genotype hepatitis E virus infection negative for anti-HEV IgM. Dig Dis Sci 2009;54:2512-2518.
90. Herremans M, Duizer E, Jusic E, Koopmans MP: Detection of hepatitis E virus-specific immunoglobulin A in patients infected with hepatitis E virus genotype 1 or 3. Clin Vaccine Immunol 2007;14:276-280.
91. Zhang F, Li X, Li Z, et al.: Detection of HEV antigen as a novel marker for the diagnosis of hepatitis E. J Med Virol 2006;78:1441-1448.
92. Zhao C, Li L, Harrison TJ, et al.: Relationships among viral diagnostic markers and markers of liver function in acute hepatitis E. J Gastroenterol 2009;44:139-145.
93. Majumdar M, Singh MP, Pujhari SK, et al.: Hepatitis E virus antigen detection as an early diagnostic marker: report from India. J Med Virol 2013; 85:823-827.
94. Inoue J, Takahashi M, Yazaki Y, et al.: Development and validation of an improved RT-PCR assay with nested universal primers for detection of hepatitis E virus strains with significant sequence divergence. J Virol Methods 2006;137: 325-333.
95. Zaki Mel S, Foud MF, Mohamed AF: Value of hepatitis E virus detection by cell culture compared with nested PCR and serological studies by IgM and IgG. FEMS Immunol Med Microbiol 2009;56:73-79.
96. Choi C, Ha SK, Chae C: Development of nested RT-PCR for the detection of swine hepatitis E virus in formalin-fixed, paraffin-embedded tissues and comparison with in situ hybridization. J Virol Methods 2004;115:67-71.
97. Jothikumar N, Cromeans TL, Robertson BH, et al.: A broadly reactive one-step real-time RTPCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods 2006;131:65-71.
98. Ward P, Poitras E, Leblanc D, et al.: Comparative analysis of different TaqMan real-time RT-PCR assays for the detection of swine hepatitis E virus and integration of feline calicivirus as internal control. J Appl Microbiol 2009;106:1360-1369.
99. Gyarmati P, Mohammed N, Norder H, et al.: Universal detection of hepatitis E virus by two realtime PCR assays: TaqMan and primer-probe energy transfer. J Virol Methods 2007;146:226-235.
100. Adlhoch C, Kaiser M, Pauli G, et al.: Indigenous hepatitis E virus infection of a plasma donor in Germany. Vox Sang 2009;97:303-308.
101. Ahn JM, Rayamajhi N, Gyun Kang S, Sang Yoo H: Comparison of real-time reverse transcriptasepolymerase chain reaction and nested or commercial reverse transcriptase-polymerase chain reaction for the detection of hepatitis E virus particle in human serum. Diagn Microbiol Infect Dis 2006;56:269-274.
102. Enouf V, Dos Reis G, Guthmann JP, et al.: Validation of single real-time taqman PCR assay for the detection and quantitation of four major genotypes of hepatitis E virus in clinical specimens. J Med Virol 2006;78:1076-1082.
103. Lan X, Yang B, Li BY, et al.: Reverse transcription-loop-mediated isothermal amplification assay for rapid detection of hepatitis E virus. J Clin Microbiol 2009;47:2304-2306.
104. Garson JA, Ferns RB, Grant PR, et al.: Minor groove binder modification of widely used taqman probe for hepatitis E virus reduces risk of false negative real-time PCR results. J Virol Methods 2012;186:157-160.
105. Baylis SA, Hanschmann KM, Blumel J, Nubling CM: Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: An initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011;49:1234-1239.
106. Baylis SA, Mizusawa S, Okada Y, Hanschmann KO: Collaborative study to establish a World Health Organization International Standard for hepatitis E virus RNA for nucleic acid amplification technology (NAT)-based assays. WHO Report 2011;WHO/BS/2011.2175.
107. Baylis SA, Blümel J, Mizusawa S, et al.: World Health Organization International Standard to harmonize assays for detection of hepatitis E RNA. Emerg Infect Dis 2013;19:729-735.
108. Abravanel F, Chapuy-Regaud S, Lhomme S, et al.: Performance of two commercial assays for detecting HEV RNA in acute or chronic infections. J Clin Microbiol 2013;51:1913-1916.
109. Ijaz S, Szypulska R, Tettmar KI, et al.: Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England. Vox Sang 2012; 102:272.
110. Fukuda S, Ishikawa M, Ochiai N, et al.: Unchanged high prevalence of antibodies to hepatitis E virus (HEV) and HEV RNA among blood donors with an elevated alanine aminotransferase level in Japan during 1991-2006. Arch Virol 2007; 152:1623-1635.
111. Worm HC, Wirnsberger G: Hepatitis E vaccines: progress and prospects. Drugs 2004;64:1517-1531.
112. Tanaka T, Takahashi M, Takahashi H, et al.: Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HEJf5/15f strain recovered from a fulminant hepatitis patient. J Clin Microbiol 2009;47:1906-1910.
113. Emerson SU, Purcell RH: Recombinant vaccines for hepatitis E. Trends Mol Med 2001;7:462-466.
114. Kamili S, Spelbring J, Carson D, Krawczynski K: Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection. J Infect Dis 2004; 189:258-264.
115. Zhou YH, Purcell RH, Emerson SU: A truncated orf2 protein contains the most immunogenic site on orf2: Antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus. Vaccine 2005;23:3157-3165.
116. Meng J, Dai X, Chang JC, et al.: Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology 2001;288:203-211.
117. Purcell RH, Nguyen H, Shapiro M, et al.: Preclinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine 2003;21: 2607-2615.
118. Li SW, Zhang J, Li YM, et al.: A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005;23:2893-2901.
119. Shrestha MP, Scott RM, Joshi DM, et al.: Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007;356:895-903.
120. Zhu FC, Zhang J, Zhang XF, et al.: Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, doubleblind placebo-controlled, phase 3 trial. Lancet 2010;376:895-902.
121. Labrique AB, Sikder SS, Krain LJ, et al.: Hepatitis E, a vaccine-preventable cause of maternal deaths. Emerg Infect Dis 2012;18:1401-1404.
122. Kamar N, Rostaing L, Abravanel F, et al.: Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology 2010;139:1612-1618.
123. Kamar N, Abravanel F, Garrouste C, et al.: Three-month pegylated interferon-Alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. Nephrol Dial Transplant 2010;25:2792-2795.
124. Kamar N, Rostaing L, Abravanel F, et al.: Pegylated interferon-Alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010;50:e30-33.
125. Chaillon A, Sirinelli A, De Muret A, et al.: Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. J Heart Lung Transplant 2011;30:841-843.
126. Baylis SA: Hepatitis E virus issues for plasma products. Oral presentation, 20th IPFA/PEI Workshop, Helsinki Finland 2013.
127. Takeda H, Matsubayashi K, Sakata H, et al.: A nationwide survey for prevalence of hepatitis E virus antibody in qualified blood donors in Japan. Vox Sang 2010;99:307-313.
128. Christensen PB, Engle RE, Hjort C, et al.: Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis 2008;47: 1026-1031.
129. Kaufmann A, Kenfak-Foguena A, Andre C, et al.: Hepatitis E virus seroprevalence among blood donors in southwest Switzerland. PloS One 2011; 6:e21150.
130. Zaaijer HL, Kok M, Lelie PN, et al.: Hepatitis E in the Netherlands: imported and endemic. Lancet 1993;341:826.
131. Beale MA, Tettmar K, Szypulska R, et al.: Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? Vox Sang 2011;100:340-342.
132. Boutrouille A, Bakkali-Kassimi L, Cruciere C, Pavio N: Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol 2007;45:2009-2010.